BANGKOK, Dec 20 (Reuters) – Thailand’s Food and Drug Administration said on Monday it has approved the use of the Pfizer-BioNTech COVID-19 vaccine for children between the age of five and 11.
The Comirnaty vaccine, which is the first to be approved in the Thailand for the age group, will be given in two 10 microgram doses, 21 days apart, the drug regulator said in a statement.
Register now for FREE unlimited access to Reuters.com
Register
Reporting by Panarat Thepgumpanat; Writing by Patpicha Tanakasempipat
Editing by Ed Davies
Our Standards: The Thomson Reuters Trust Principles.